Annual CFF
$30.78 M
+$23.48 M+321.77%
December 31, 2023
Summary
- As of February 8, 2025, BIOR annual cash flow from financing activities is $30.78 million, with the most recent change of +$23.48 million (+321.77%) on December 31, 2023.
- During the last 3 years, BIOR annual CFF has fallen by -$198.94 million (-86.60%).
- BIOR annual CFF is now -86.60% below its all-time high of $229.72 million, reached on December 1, 2020.
Performance
BIOR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$6.62 M
+$983.00 K+17.44%
September 30, 2024
Summary
- As of February 8, 2025, BIOR quarterly cash flow from financing activities is $6.62 million, with the most recent change of +$983.00 thousand (+17.44%) on September 30, 2024.
- Over the past year, BIOR quarterly CFF has stayed the same.
- BIOR quarterly CFF is now -94.29% below its all-time high of $116.02 million, reached on June 1, 2020.
Performance
BIOR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$31.27 M
+$9.47 M+43.42%
September 30, 2024
Summary
- As of February 8, 2025, BIOR TTM cash flow from financing activities is $31.27 million, with the most recent change of +$9.47 million (+43.42%) on September 30, 2024.
- Over the past year, BIOR TTM CFF has stayed the same.
- BIOR TTM CFF is now -87.04% below its all-time high of $241.37 million, reached on March 1, 2021.
Performance
BIOR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BIOR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +321.8% | 0.0% | 0.0% |
| 3 y3 years | -86.6% | 0.0% | 0.0% |
| 5 y5 years | +340.4% | 0.0% | 0.0% |
BIOR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -81.3% | +321.8% | -91.0% | +332.4% | -81.0% | +328.5% |
| 5 y | 5-year | -86.6% | +321.8% | -94.3% | +332.4% | -87.0% | +328.5% |
| alltime | all time | -86.6% | +340.4% | -94.3% | +245.6% | -87.0% | +755.5% |
Biora Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.62 M(+17.4%) | $31.27 M(+43.4%) |
| Jun 2024 | - | $5.64 M(+10.5%) | $21.81 M(-8.4%) |
| Mar 2024 | - | $5.10 M(-63.4%) | $23.80 M(-22.7%) |
| Dec 2023 | $30.78 M(+321.8%) | $13.92 M(-588.7%) | $30.78 M(+44.0%) |
| Sep 2023 | - | -$2.85 M(-137.3%) | $21.38 M(-6.0%) |
| Jun 2023 | - | $7.63 M(-36.8%) | $22.75 M(+40.0%) |
| Mar 2023 | - | $12.08 M(+167.5%) | $16.25 M(+122.6%) |
| Dec 2022 | $7.30 M(-95.6%) | $4.52 M(-405.8%) | $7.30 M(-90.4%) |
| Sep 2022 | - | -$1.48 M(-231.3%) | $76.32 M(-30.3%) |
| Jun 2022 | - | $1.13 M(-64.1%) | $109.57 M(-24.9%) |
| Mar 2022 | - | $3.13 M(-95.7%) | $145.96 M(-11.6%) |
| Dec 2021 | $165.05 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $73.54 M(+131.5%) | $165.05 M(-15.6%) |
| Sep 2021 | - | $31.77 M(-15.3%) | $195.46 M(+20.0%) |
| Jun 2021 | - | $37.52 M(+68.8%) | $162.86 M(-32.5%) |
| Mar 2021 | - | $22.23 M(-78.6%) | $241.37 M(+5.1%) |
| Dec 2020 | $229.72 M(+212.0%) | $103.95 M(<-9900.0%) | $229.72 M(+28.0%) |
| Sep 2020 | - | -$834.00 K(-100.7%) | $179.41 M(-12.5%) |
| Jun 2020 | - | $116.02 M(+996.2%) | $205.01 M(+131.0%) |
| Mar 2020 | - | $10.58 M(-80.3%) | $88.77 M(+20.5%) |
| Dec 2019 | $73.64 M(-675.0%) | $53.65 M(+116.6%) | $73.64 M(+268.3%) |
| Sep 2019 | - | $24.76 M(<-9900.0%) | $19.99 M(-519.0%) |
| Jun 2019 | - | -$225.00 K(-95.1%) | -$4.77 M(+4.9%) |
| Mar 2019 | - | -$4.55 M | -$4.55 M |
| Dec 2018 | -$12.81 M | - | - |
FAQ
- What is Biora Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Biora Therapeutics?
- What is Biora Therapeutics annual CFF year-on-year change?
- What is Biora Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Biora Therapeutics?
- What is Biora Therapeutics quarterly CFF year-on-year change?
- What is Biora Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Biora Therapeutics?
- What is Biora Therapeutics TTM CFF year-on-year change?
What is Biora Therapeutics annual cash flow from financing activities?
The current annual CFF of BIOR is $30.78 M
What is the all time high annual CFF for Biora Therapeutics?
Biora Therapeutics all-time high annual cash flow from financing activities is $229.72 M
What is Biora Therapeutics annual CFF year-on-year change?
Over the past year, BIOR annual cash flow from financing activities has changed by +$23.48 M (+321.77%)
What is Biora Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of BIOR is $6.62 M
What is the all time high quarterly CFF for Biora Therapeutics?
Biora Therapeutics all-time high quarterly cash flow from financing activities is $116.02 M
What is Biora Therapeutics quarterly CFF year-on-year change?
Over the past year, BIOR quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Biora Therapeutics TTM cash flow from financing activities?
The current TTM CFF of BIOR is $31.27 M
What is the all time high TTM CFF for Biora Therapeutics?
Biora Therapeutics all-time high TTM cash flow from financing activities is $241.37 M
What is Biora Therapeutics TTM CFF year-on-year change?
Over the past year, BIOR TTM cash flow from financing activities has changed by $0.00 (0.00%)